Repeated administration of mirtazapine inhibits development of hyperalgesia/allodynia and activation of NF-κB in a rat model of neuropathic pain

Neuroscience Letters

Volumn 433, Issue 1, 2008, Pages 33-37

  Zhu, Juan ^a   Wei, Xiaowei ^a   Feng, Xiaomei ^a   Song, Juan ^a   Hu, Yimin ^a   Xu, Jianguo ^a  

^a JINLING HOSPITAL   (China)

Author keywords

Cytokines; Hyperalgesia; Mirtazapine; Neuropathic pain; NF B

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; MIRTAZAPINE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ALLODYNIA; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; ELECTROPHORETIC MOBILITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HYPERALGESIA; MALE; NERVE TRANSECTION; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BRAIN; CYTOKINES; DENERVATION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; DRUG ADMINISTRATION SCHEDULE; HYPERALGESIA; INTERLEUKIN-10; INTERLEUKIN-1BETA; MALE; MIANSERIN; NEURAL PATHWAYS; NEURALGIA; NF-KAPPA B; PAIN MEASUREMENT; RATS; RATS, SPRAGUE-DAWLEY; SPINAL NERVES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 39149085669     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2007.12.037     Document Type: Article

References (33)

1. Acton J., McKenna J.E., and Melzack R. Amitriptyline produces analgesia in the formalin pain test. Exp. Neurol. 117 1 (1992) 94-96
2. De Boer T. The effects of mirtazapine on central noradrenergic and serotonergic neurotransmission. Int. Clin. Psychopharmacol. 10 Suppl. 4 (1996) 19-23
3. De Boer T., Maur G., Raitieri M., De Vos C.J., Wieringa J., and Pinder R.M. Neurochemical and autonomic profiles of the 6-aza-analogue of mianserin, Org 3770 and its enantiomers. Neuropharmacology 27 (1988) 399-408
4. DeLeo J.A., Tanga F.Y., and Tawfik V.L. Neuroimmune activation and neuroinflammation in chronic pain and opioid tolerance/hyperalgesia. Neuroscientist 10 1 (2004) 40-52
5. Dickenson S. Spinal and supraspinal contributions to central sensitization in peripheral neuropathy. Neurosignals 14 4 (2005) 175-181
6. Duman R.S., Heninger G.R., and Nestler E.J. A molecular and cellular theory of depression. Arch Gen Psychiatry 54 (1997) 597-606
7. Falchi M., Ferrara F., Gharib C., and Dib B. Hyperalgesic effect of intrathecally administered interleukin-1 in rats. Drugs Exp. Clin. Res. 27 3 (2001) 97-101
8. Guo C.J., Douglas S.D., Gao Z., Wolf B.A., Grinspan J., Lai J.P., Riedel E., and Ho W.Z. Interleukin-1 beta upregulates functional expression of neurokinin-1 receptor (NK-1R) via NF-kappaB in astrocytes. Glia 48 Nov (3) (2004) 259-266
9. Hargreaves K., Dubner R., Brown F., Flores C., and Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32 (1988) 77-88
10. Holm K., and Markham A. Mirtazapine: a review of its use in major depression. Drugs 57 (1999) 607-631
11. Ignatowski T.A., Covey W.C., Knight P.R., Severin C.M., Nickola T.J., and Spengler R.N. Brain-derived TNFalpha mediates neuropathic pain. Brain Res. 11 (1999) 70-77
12. Jörgen Bengtsson H., Julianna Kele, Johan Johansson, and Stephan Hjorth. Interaction of the antidepressant mirtazapine with α2-adrenoceptors modulating the release of 5-HT in different rat brain regions in vivo. Naunyn-Schmiedeberg's Arch. Pharmacol. 362 (2000) 406-412
13. Kanaan S.A., Poole S., Saade N.E., Jabbur S., and Safieh-Garabedian B. Interleukin-10 reduces the endotoxin-induced hyperalgesia in mice. J. Neuroimmunol. 86 (1998) 142-150
14. Kast R.E. Anti- and pro-inflammatory considerations in antidepressant use during medical illness: bupropion lowers and mirtazapine increases circulating tumor necrosis factor-alpha levels. Gen. Hosp. Psychiatry 25 6 (2003) 49
15. Kim S.H., and Chung J.M. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 50 (1992) 355-363
16. Kraus J., Borner C., Giannini E., and Hollt V. The role of nuclear factor kappaB in tumor necrosis factor-regulated transcription of the human mu-opioid receptor gene. Mol. Pharmacol. 64 (2003) 876-884
17. Lee H.L., Lee K.M., Son S.J., Hwang S.H., and Cho H.J. Temporal expression of cytokines and their receptors mRNAs in a neuropathic pain model. Neuroreport 15 (2004) 2807-2011
18. Liu Z., Yu Y., Jiang Y., and Li J. Growth hormone increases lung NF-kappaB activation and lung microvascular injury induced by lipopolysaccharide in rats. Ann. Clin. Lab. Sci. 32 (2002) 164-170
19. Lv R., Zhou W., Chu C., and Xu J. Mechanism of the effect of hydroxyethyl starch on reducing pulmonary capillary permeability in a rat model of sepsis. Ann. Clin. Lab. Sci. 35 (2005) 174-183
20. Milligan E.D., Langer S.J., Sloane E.M., He L., Wieseler-Frank J., and O'Connor K.A. Controlling pathological pain by adenovirally driven spinal production of the anti-inflammatory cytokine, Interleukin-10. Eur. J. Neurosci. 21 (2005) 2136-2148
21. Milligan E.D., Sloane E.M., and Langer S.J. Repeated intrathecal injections of plasmid DNA encoding interleukin-10 produce prolonged reversal of neuropathic pain. Pain 126 (2006) 294-308
22. Moore K.W., deWaal Malefyt R., Coffman R.L., and O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19 (2001) 683-765
23. O'eill L.A., and Kaltschmidt C. NF-kappa B: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci. 20 6 (1997) 252-258
24. Pacher P., Kohegyi E., Kecskemeti V., and Frust S. Current trends in the development of new antidepressants. Curr. Med. Chem. 8 (2001) 89-100
25. Rogoz Z., Skuza G., and Legutko B. Repeated treatment with mirtazepine induces brain-derived neurotrophic factor gene expression in rats. J. Physiol. Pharmacol. 56 4 (2005) 661-671
26. Sakaue G., Shimaoka M., and Fukuoka T. NF-kappa B decoy suppresses cytokine expression and thermal hyperalgesia in a rat neuropathic pain model. Neuroreport 12 (2001) 2079-2084
27. Sweitzer S., Martin D., and DeLeo J.A. Intrathecal interleukin-1 receptor antagonist in combination with soluble tumor necrosis factor receptor exhibits an anti-allodynic action in a rat model of neuropathic pain. Neuroscience 103 (2001) 529-539
28. Tegeder I., Niederberger E., and Schmidt R. Specific inhibition of IkappaB kinase reduces hyperalgesia in inflammatory and neuropathic pain models in rats. J. Neurosci. 24 (2004) 1637-1645
29. Watkins L.R., and Maier S.F. Glia: a novel drug discovery target for clinical pain. Nat. Rev. Drug Discov. 2 (2003) 973-985
30. Watkins L.R., Maier S.F., and Goehler L.E. Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain 63 3 (1995) 289-302
31. Watkins L.R., Milligan E.D., and Maier S.F. Glial activation: a driving force for pathological pain. Trends Neurosci. 8 (2001) 450-455
32. Watkins L.R., Milligan E.D., and Maier S.F. Glial proinflammatory cytokines mediate exaggerated pain states: implications for clinical pain. Adv. Exp. Med. Biol. 521 (2003) 1-21
33. Xie W., and Luo S. Effect of betamethasone on neuropathic pain and cerebral expressions of NF-κ B and cytokines. Neurosci. Lett. 393 (2006) 255-259